文献速递性腺与生殖内分泌

育龄期女性雄激素的正常范围:年龄、月经周期与BMI的影响

Androgens During the Reproductive Years: What Is Normal for Women?
PubMed 文献 · J Clin Endocrinol Metab · 2019-01-01

该横断面研究纳入588名18-39岁月经规律、无PCOS诊断的女性,用液相色谱-串联质谱法检测雄激素。发现睾酮和雄烯二酮在月经周期中晚期显著高于早卵泡期,而11-氧代C19类固醇(11KA、11KT)无周期波动;超重女性睾酮、DHEA和11KA中位数低于正常体重者;所有C19雄激素在35-39岁组显著低于18-25岁组。结论提示需按年龄制定绝经前女性雄激素参考范围。

要点

  • 11KA和11KT在月经周期中稳定,对循环雄激素池有重要贡献。
  • 超重女性睾酮、DHEA和11KA中位数显著低于正常体重女性。
  • 所有C19雄激素随年龄增长而下降,需年龄特异性参考范围。

核心结论

  • 11KA和11KT在月经周期中稳定,且对循环雄激素池有重要定量贡献。
  • 所有C19雄激素在绝经前随年龄下降,因此需要年龄特异性参考范围来解读育龄期女性雄激素水平。

研究设计与样本

  • 横断面研究,从澳大利亚东部各州招募588名18-39岁女性。
  • 纳入标准:未妊娠、未哺乳、未使用全身性激素治疗、月经周期规律且无多囊卵巢综合征诊断。
  • 主要结局指标:用液相色谱-串联质谱法测定性类固醇。

主要发现

  • 睾酮和雄烯二酮在月经周期中晚期显著高于早卵泡期,周期中位值分别为0.34 nmol/L(范围0.04-1.01)和1.97 nmol/L(范围0.53-7.89)。
  • DHEA(4.91 nmol/L;范围0.08-23.51)、11KA(7.99 nmol/L;范围0.07-31.67)和11KT(1.27 nmol/L;范围0.03-7.61)无周期性变化。
  • 超重女性睾酮(P < 0.05)、DHEA(P < 0.05)和11KA(P < 0.01)中位数低于正常体重女性。
  • 35-39岁组所有C19类固醇显著低于18-25岁组(P < 0.01)。
  • 11KA/雄烯二酮中位比值(4.3:1)和11KT/睾酮中位比值(3.9:1)在调整BMI和周期阶段后不随年龄变化。

临床怎么用

  • 解读育龄期女性雄激素水平时应考虑年龄因素,使用年龄特异性参考范围。
  • 月经周期阶段影响睾酮和雄烯二酮水平,采血时需记录周期阶段。
  • 11KA和11KT可作为稳定的雄激素指标,不受月经周期影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Whether serum androgen levels can identify women with "androgen insufficiency" or "androgen excess" is unresolved; thus, what constitutes "normal" remains uncertain. We sought to determine whether androgens, including 11-oxygenated C19 steroids, vary with age, menstrual cycle, or body mass index (BMI), during the reproductive years. DESIGN AND SETTING: Cross-sectional study recruited from eastern Australian states. PARTICIPANTS: A total of 588 women, aged 18 to 39 years, who were not pregnant, lactating, or using systemic hormone therapy, with regular menstrual cycles and no previous diagnosis of polycystic ovarian syndrome. MAIN OUTCOME MEASURES: Sex steroids measured using liquid chromatography-tandem mass spectrometry. RESULTS: Testosterone and androstenedione concentrations were significantly higher during the menstrual cycle mid- and luteal phases than in the early follicular phase, with median values across the cycle of 0.34 nmol/L (range, 0.04 to 1.01) and 1.97 nmol/L (range, 0.53 to 7.89), respectively. No cyclical variations were found in dehydroepiandrosterone (DHEA; 4.91 nmol/L; range, 0.08 to 23.51), 11-ketoandrostenedione (11KA; 7.99 nmol/L; range, 0.07 to 31.67), or 11-ketotestosterone (11KT; 1.27 nmol/L; range, 0.03 to 7.61). Overweight women had lower median testosterone (P < 0.05), DHEA (P < 0.05), and 11KA (P < 0.01) levels than normal-weight women. All C19 steroids were significantly lower (P < 0.01) in those aged 35 to 39 years than in those aged 18 to 25 years. The median 11KA/androstenedione (4.3:1) and 11KT/testosterone (3.9:1) ratios did not change with age, after adjustment for BMI and cycle stage. CONCLUSIONS: We have demonstrated that 11KA and 11KT are stable across the menstrual cycle and make major quantitative contributions to the circulating androgen pool. All C19 androgens declined with age before menopause; hence, age-specific reference ranges are required for the interpretation of androgen levels in premenopausal women.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Skiba MA, Bell RJ, Islam RM, et al. Androgens During the Reproductive Years: What Is Normal for Women? J Clin Endocrinol Metab. 2019. PMID: 31390028. doi:10.1210/jc.2019-01357

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。